{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:10:23Z","timestamp":1793880623397,"version":"4.7.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJID Regions"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ijregi.2024.03.004","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T08:37:50Z","timestamp":1710319070000},"page":"100349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Assessing the influence of the COVID-19 pandemic on the incidence, clinical presentation, and clindamycin resistance rates of Streptococcus pyogenes infections"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3412-7563","authenticated-orcid":false,"given":"Daniel N.","family":"Marco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Canela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Brey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9374-0811","authenticated-orcid":false,"given":"Alex","family":"Soriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Pitart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5057-354X","authenticated-orcid":false,"given":"Sabina","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijregi.2024.03.004_bib0001","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.idc.2022.07.007","article-title":"ICU management of invasive \u03b2-hemolytic streptococcal infections","volume":"36","author":"Babiker","year":"2022","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.ijregi.2024.03.004_bib0002","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.anpedi.2019.10.014","article-title":"Invasive Streptococcus pyogenes infections (2011\u20132018): EMM-type and clinical presentation","volume":"92","author":"Gonz\u00e1lez-Abad","year":"2020","journal-title":"An Pediatr (Engl Ed)"},{"key":"10.1016\/j.ijregi.2024.03.004_bib0003","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.eimc.2023.04.003","article-title":"Streptococcus pyogenes infections in Spanish children before and after the COVID pandemic. Coming back to the previous incidence","volume":"42","author":"de Ceano-Vivas","year":"2024","journal-title":"Enferm Infecc Microbiol Clin (Engl)"},{"key":"10.1016\/j.ijregi.2024.03.004_bib0004","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2023.28.1.2200941","article-title":"Increase in invasive group A streptococcal (Streptococcus pyogenes) infections (iGAS) in young children in the Netherlands, 2022","volume":"28","author":"De Gier","year":"2023","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijregi.2024.03.004_bib0005","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1016\/S2352-4642(22)00374-1","article-title":"Paediatric group A streptococcal disease in England from October to December, 2022","volume":"7","author":"Ladhani","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.ijregi.2024.03.004_bib0006","unstructured":"Centers for Disease Control and Prevention. Surveillance for Group A strep disease, https:\/\/www.cdc.gov\/groupastrep\/surveillance.html; 2022 [accessed 16 December 2023]."},{"key":"10.1016\/j.ijregi.2024.03.004_bib0007","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-063023","article-title":"Prognostic factors for streptococcal toxic shock syndrome: systematic review and meta-analysis","volume":"12","author":"Bartoszko","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijregi.2024.03.004_bib0008","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1128\/AAC.47.5.1752-1755.2003","article-title":"Influences of linezolid, penicillin, and clindamycin, alone and in combination, on streptococcal pyrogenic exotoxin a release","volume":"47","author":"Coyle","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijregi.2024.03.004_bib0009","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1128\/AAC.49.1.88-96.2005","article-title":"Effect of antibiotics on group A streptococcus exoprotein production analyzed by two-dimensional gel electrophoresis","volume":"49","author":"Tanaka","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijregi.2024.03.004_bib0010","first-page":"269","article-title":"Clindamycin affects Group A streptococcus virulence factors and improves clinical outcome","volume":"215","author":"Andreoni","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijregi.2024.03.004_bib0011","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13017-018-0219-9","article-title":"2018 WSES\/SIS-E consensus conference: recommendations for the management of skin and soft-tissue infections","volume":"13","author":"Sartelli","year":"2018","journal-title":"World J Emerg Surg"},{"key":"10.1016\/j.ijregi.2024.03.004_bib0012","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/cid\/ciu444","article-title":"Executive summary: practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijregi.2024.03.004_bib0013","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/1120009X.2017.1311398","article-title":"Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update","volume":"29","author":"Esposito","year":"2017","journal-title":"J Chemother"},{"key":"10.1016\/j.ijregi.2024.03.004_bib0014","doi-asserted-by":"crossref","first-page":"475","DOI":"10.37201\/req\/030.2022","article-title":"Clindamycin but not intravenous Immunoglobulins reduces mortality in a retrospective cohort of critically ill patients with bacteremic Group A Streptococcal infections","volume":"35","author":"Fern\u00e1ndez-Galilea","year":"2022","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.ijregi.2024.03.004_bib0015","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S1473-3099(20)30523-5","article-title":"Effectiveness of adjunctive clindamycin in \u03b2-lactam antibiotic-treated patients with invasive \u03b2-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study","volume":"21","author":"Babiker","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijregi.2024.03.004_bib0016","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/INF.0000000000001442","article-title":"Macrolide and clindamycin resistance in group a streptococci isolated from children with pharyngitis","volume":"36","author":"DeMuri","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ijregi.2024.03.004_bib0017","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jmii.2013.08.015","article-title":"The trend of macrolide resistance and emm types of group A streptococci from children at a medical center in southern Taiwan","volume":"48","author":"Chuang","year":"2015","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijregi.2024.03.004_bib0018","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1093\/cid\/ciab575","article-title":"Patterns of antibiotic nonsusceptibility among invasive Group A streptococcus infections-United States, 2006\u20132017","volume":"73","author":"Fay","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijregi.2024.03.004_bib0019","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.1993.03500030088038","article-title":"Defining the Group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections","volume":"269","author":"Breiman","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.ijregi.2024.03.004_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1008292","article-title":"After the honeymoon, the divorce: unexpected outcomes of disease control measures against endemic infections","volume":"16","author":"Hollingsworth","year":"2020","journal-title":"PLOS Comput Biol"},{"key":"10.1016\/j.ijregi.2024.03.004_bib0021","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/cid\/ciac720","article-title":"Should linezolid replace clindamycin as the adjunctive antimicrobial of choice in Group A streptococcal necrotizing soft tissue infection and toxic shock syndrome? A focused debate","volume":"76","author":"Cort\u00e9s-Penfield","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijregi.2024.03.004_bib0022","doi-asserted-by":"crossref","first-page":"ofad588","DOI":"10.1093\/ofid\/ofad588","article-title":"Comparison of Adjuvant clindamycin vs linezolid for severe invasive Group A Streptococcal skin and soft tissue infections","volume":"10","author":"Heil","year":"2023","journal-title":"Open Forum Infect Dis"}],"container-title":["IJID Regions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707624000195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772707624000195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T07:11:15Z","timestamp":1718867475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772707624000195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":22,"alternative-id":["S2772707624000195"],"URL":"https:\/\/doi.org\/10.1016\/j.ijregi.2024.03.004","relation":{},"ISSN":["2772-7076"],"issn-type":[{"value":"2772-7076","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the influence of the COVID-19 pandemic on the incidence, clinical presentation, and clindamycin resistance rates of Streptococcus pyogenes infections","name":"articletitle","label":"Article Title"},{"value":"IJID Regions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijregi.2024.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"100349"}}